Chang-you Wu

Title: Chang-you Wu: Innovator in Antibody Research

Introduction

Chang-you Wu is a notable inventor based in Belleville, NJ (US), recognized for his contributions to the field of antibody research. His innovative work has led to the development of a novel antibody targeting the interleukin-12 receptor, which has significant implications for therapeutic applications.

Latest Patents

Chang-you Wu holds a patent for an antibody to the interleukin-12 receptor. The patent describes a novel antibody against the IL-12 receptor, specifically designated as 2B10. This antibody binds to the human IL-12 receptor but does not inhibit the binding of human IL-12 to the high-affinity human IL-12 receptor. Furthermore, it is not capable of neutralizing human IL-12 bioactivity by binding to the human IL-12 receptor. This innovation represents a significant advancement in the understanding and potential treatment of diseases related to the IL-12 receptor.

Career Highlights

Chang-you Wu is associated with Hoffmann-La Roche Inc., a leading company in the pharmaceutical industry. His work at the company has allowed him to focus on groundbreaking research in immunology and antibody development. His contributions have been instrumental in advancing the field and improving therapeutic options for patients.

Collaborations

Chang-you Wu has collaborated with notable colleagues, including Maurice Kent Gately and David Howard Presky. These collaborations have fostered a productive research environment, leading to significant advancements in their shared field of study.

Conclusion

Chang-you Wu's innovative work in antibody research, particularly his patent on the IL-12 receptor antibody, showcases his commitment to advancing medical science. His contributions continue to influence the field and hold promise for future therapeutic developments.